Xiang Yang Lu
Vorstandsvorsitzender bei LAEKNA, INC.
Vermögen: 43 Mio $ am 31.05.2024
Aktive Positionen von Xiang Yang Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LAEKNA, INC. | Vorstandsvorsitzender | 29.07.2016 | - |
| Vorsitzender | 29.07.2016 | - | |
| Gründer | 29.07.2016 | - | |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 01.12.2016 | - | |
| Gründer | 01.12.2016 | - | |
| Laekna Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Xiang Yang Lu
Ehemalige bekannte Positionen von Xiang Yang Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Direktor/Vorstandsmitglied | 01.09.2003 | 01.03.2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.09.2003 | 01.03.2016 |
| Frontline Bioventures | Corporate Officer/Principal | 01.01.2016 | - |
Ausbildung von Xiang Yang Lu
| Nankai University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistik
International
| China | 5 |
| Vereinigte Staaten | 3 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Frontline Bioventures | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Laekna Ltd. | |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Börse
- Insiders
- Xiang Yang Lu
- Erfahrung